Sign in

CIK 0001023024 · Large accelerated filer

ANI PHARMACEUTICALS INC

Sign in to watch
Ticker
ANIP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
582301143
Phone
6097591810
Business address
104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
Former names
BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
  1. 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 500 shares at $75.48 ($37,740)
  2. 4 Open-market sale SVP, GENERICS sold 3,162 shares at $77.00 ($243,474)
  3. 10-Q Report Quarterly Report
  4. 8-K Event Results of operations · Regulation FD disclosure
  5. 4 Planned sale SVP & CFO sold 2,850 shares at $81.36 ($231,876)
  6. 144 Insider Sale of Securities
  7. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  8. 4 Shares withheld for taxes SR. VP, GENERAL COUNSEL & SEC. gave up 2,466 shares (to pay taxes)
  9. S-8 Other Securities Offered to Employees in Benefit Plans
  10. 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 500 shares at $81.84 ($40,920)
  11. 144 Insider Sale of Securities
  12. 4 Planned sale SVP & CFO sold 3,313 shares at $86.00 ($284,918)
  13. 4 Planned sale SVP & CFO sold 2,850 shares at $84.12 ($239,742)
  14. 4 Planned sale SR. VP, GENERAL COUNSEL & SEC. sold 500 shares at $82.03 ($41,015)
  15. 4 Grant or award Director acquired 4,357 shares (grant or award)
  16. 4 Grant or award Director acquired 4,357 shares (grant or award)
  17. 4 Grant or award Director acquired 4,357 shares (grant or award)
  18. 4 Grant or award Director acquired 4,357 shares (grant or award)
  19. 4 Planned sale Director sold 2,000 shares at $80.88 ($161,760)
  20. 4 Planned sale SVP & CFO sold 3,312 shares at $80.00 ($264,960)

Page 2 of 90 · 1,784 filings